ArticleJAMA neurology2024

Direct to Consumer Biomarker Testing for Alzheimer Disease-Are We Ready for the Insurance Consequences?

Jalayne J Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.